Shareholders Foundation, Inc.

NASDAQ:CRBU Investor Alert: Deadline on April 11, 2023 in Lawsuit Against Caribou Biosciences, Inc. Coming Up

A Deadline is coming up on April 11, 2023 in the lawsuit for certain investors in Caribou Biosciences, Inc. (NASDAQ:CRBU).

 

San Diego, CA -- (SBWIRE) -- 04/05/2023 -- The Shareholders Foundation announced that a deadline is coming up on April 11, 2023 in the lawsuit filed for certain investors of Caribou Biosciences, Inc. (NASDAQ: CRBU).

Investors who purchased shares of Caribou Biosciences, Inc. (NASDAQ: CRBU) have certain options and there are strict and short deadlines running. Deadline: April 11, 2023. NASDAQ: CRBU stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Caribou Biosciences, Inc. (NASDAQ: CRBU) common shares who purchased NASDAQ: CRBU shares pursuant and/or traceable in connection with the Company's July 23, 2021 IPO and or between July 23, 2021 and December 9, 2022, that the defendants violated Federal Securities Laws.

The plaintiff claims that the Offering Documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, the plaintiff alleges that between July 23, 2021 and December 9, 2022, the Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.

More specifically, the plaintiff claims that the Offering Documents and the Defendants made false and/or misleading statements and/or failed to disclose thatCB-010's treatment effect was not as durable as Defendants had led investors to believe, that accordingly, CB-010's clinical and commercial prospects were overstated, and that as a result, the Offering Documents and Defendants' public statements between July 23, 2021 and December 9, 2022 were materially false and/or misleading and failed to state information required to be stated therein.

Those who purchased shares of Caribou Biosciences, Inc. (NASDAQ: CRBU) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.